Logo: to the web site of Uppsala University

uu.sePublications from Uppsala University
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Structural Mapping of Adenosine Receptor Mutations: Ligand Binding and Signaling Mechanisms
Uppsala University, Disciplinary Domain of Science and Technology, Biology, Department of Cell and Molecular Biology, Computational Biology and Bioinformatics. Leiden Amsterdam Ctr Drug Res, Drug Discovery & Safety, Leiden.; Univ Copenhagen, Dept Drug Design & Pharmacol, Copenhagen.ORCID iD: 0000-0002-4951-9220
PharmaCtr Bonn, Pharmaceut Inst, Pharmaceut Chem 1, Bonn.
Leiden Amsterdam Ctr Drug Res, Drug Discovery & Safety, Leiden.
Heptares Therapeut, Biopk, Broadwater Rd, Welwyn Garden City, Herts.
Show others and affiliations
2018 (English)In: TIPS - Trends in Pharmacological Sciences, ISSN 0165-6147, E-ISSN 1873-3735, Vol. 39, no 1, p. 75-89Article, review/survey (Refereed) Published
Abstract [en]

The four adenosine receptors (ARs), A(1), A(2A), A(2B), and A(3), constitute a subfamily of G protein-coupled receptors (GPCRs) with exceptional foundations for structure-based ligand design. The vast amount of mutagenesis data, accumulated in the literature since the 1990s, has been recently supplemented with structural information, currently consisting of several inactive and active structures of the A(2A) and inactive conformations of the A(1) ARs. We provide the first integrated view of the pharmacological, biochemical, and structural data available for this receptor family, by mapping onto the relevant crystal structures all site-directed mutagenesis data, curated and deposited at the GPCR database (available through http://www.gpcrdb.org). This analysis provides novel insights into ligand binding, allosteric modulation, and signaling of the AR family.

Place, publisher, year, edition, pages
2018. Vol. 39, no 1, p. 75-89
National Category
Pharmacology and Toxicology Structural Biology
Identifiers
URN: urn:nbn:se:uu:diva-347706DOI: 10.1016/j.tips.2017.11.001ISI: 000418597900006PubMedID: 29203139OAI: oai:DiVA.org:uu-347706DiVA, id: diva2:1195698
Funder
Swedish Research Council, 521-2014-2118European Regional Development Fund (ERDF)German Research Foundation (DFG), FOR2372Available from: 2018-04-06 Created: 2018-04-06 Last updated: 2020-03-30Bibliographically approved
In thesis
1. Free energy calculations of G protein-coupled receptor modulation: New methods and applications
Open this publication in new window or tab >>Free energy calculations of G protein-coupled receptor modulation: New methods and applications
2020 (English)Doctoral thesis, comprehensive summary (Other academic)
Abstract [en]

G protein-coupled receptors (GPCRs) are membrane proteins that transduce the signals of extracellular ligands, such as hormones, neurotransmitters and metabolites, through an intracellular response via G proteins. They are abundant in human physiology and approximately 34% of the marketed drugs target a GPCR. Upon activation, the receptor undergoes conformational changes to accommodate the binding of the G protein. Our insights in the structural determinants of ligand binding and receptor activation have increased tremendously over the past decade. This has largely been a cause of the growing amount of experimentally determined structures, which provide crucial insights in ligand binding mechanisms. However, in a typical drug design project it is unlikely that such structures can be generated for all ligands. In those cases, computationally derived models of the protein-ligand complex can be generated. Rigorous free energy calculations such as the free energy perturbation (FEP) method, can subsequently provide the missing link between those structures and experimental ligand binding data, and provide further insights in the binding mechanism.

In this thesis, two workflows are presented to calculate free energies of binding for ligands to wildtype (QligFEP) and mutant (QresFEP) receptors. Both methods were tested on a set of solvation free energies of sidechain mimics. QligFEP was furthermore applied on three protein-ligand binding datasets, including pair comparisons between topologically unrelated molecules (scaffold hopping). QresFEP was used to calculate protein-ligand binding affinities to mutants of the neuropeptide Y1, and to predicte the effect of receptor modifications on the thermal stability of T4 lysozyme.

The remainder of this work focussed on the application of these protocols in the design, synthesis and molecular pharmacology of ligands for the family of adenosine receptor (ARs). These receptors, involved in many physiological processes such as promotion of sleep (caffeine is a well-known inhibitor), have recently been pursued as drug targets in immuno-oncology. QligFEP was used in the design of novel series of antagonists for the A3AR and A2BAR. QresFEP was used to study ligand binding to the A1AR and in a multidisciplinary approach to characterize binding to the orphan receptor GPR139. Both approaches were combined to design a series of A2AAR antagonist, and to propose a binding mode later confirmed by new crystal structures. Finally, a new application of FEP is introduced based on conformational equilibria between the active and inactive A2AAR, to elucidate the regulation mechanism of receptor activation by ligands and receptor mutations.

Place, publisher, year, edition, pages
Uppsala: Acta Universitatis Upsaliensis, 2020. p. 101
Series
Digital Comprehensive Summaries of Uppsala Dissertations from the Faculty of Science and Technology, ISSN 1651-6214 ; 1925
Keywords
G protein-coupled receptor, adenosine receptor, molecular dynamics, free energy perturbation, homology modeling, computer simulations, conformational selectivity, binding free energy.
National Category
Bioinformatics (Computational Biology) Biochemistry Molecular Biology
Research subject
Biology with specialization in Molecular Biotechnology
Identifiers
urn:nbn:se:uu:diva-407840 (URN)978-91-513-0927-9 (ISBN)
Public defence
2020-05-20, A1:111a,, Uppsala Biomedical Centre (BMC), Husargatan 3, Uppsala, 13:15 (English)
Opponent
Supervisors
Available from: 2020-04-29 Created: 2020-03-30 Last updated: 2025-02-20

Open Access in DiVA

No full text in DiVA

Other links

Publisher's full textPubMed

Authority records

Jespers, WillemGutiérrez-de-Terán, Hugo

Search in DiVA

By author/editor
Jespers, WillemGutiérrez-de-Terán, Hugo
By organisation
Computational Biology and Bioinformatics
In the same journal
TIPS - Trends in Pharmacological Sciences
Pharmacology and ToxicologyStructural Biology

Search outside of DiVA

GoogleGoogle Scholar

doi
pubmed
urn-nbn

Altmetric score

doi
pubmed
urn-nbn
Total: 276 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf